18F-radiolabeled MCT1/MCT4 inhibitor (Helmholtz-Zentrum Dresden-Rossendorf)

N/A

Report date: 2025/01/26 18:11:51

Base Information

Drug Name18F-radiolabeled MCT1/MCT4 inhibitor (Helmholtz-Zentrum Dresden-Rossendorf)
Drug Alias NameN/A
ClassificationRadiation-emitting products
Mechanisms of ActionMonocarboxylate transporter 4 inhibitorsMonocarboxylate transporter 1 inhibitors
TargetsMonocarboxylate transporter 4Monocarboxylate transporter 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHelmholtz-Zentrum Dresden-Rossendorf
China Registration ClassN/A

Develop Information

Active CompaniesHelmholtz-Zentrum Dresden-Rossendorf
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A